Display options
Cite
Perumal JS, Kister I, Howard J, et al. Disease exacerbation after rituximab induction in neuromyelitis optica. Neurol Neuroimmunol Neuroinflamm. 2015;2(1):e61doi: 10.1212/NXI.0000000000000061.
Perumal, J. S., Kister, I., Howard, J., & Herbert, J. (2015). Disease exacerbation after rituximab induction in neuromyelitis optica. Neurology(R) neuroimmunology & neuroinflammation, 2(1), e61. https://doi.org/10.1212/NXI.0000000000000061
Perumal, Jai S, et al. "Disease exacerbation after rituximab induction in neuromyelitis optica." Neurology(R) neuroimmunology & neuroinflammation vol. 2,1 (2015): e61. doi: https://doi.org/10.1212/NXI.0000000000000061
Perumal JS, Kister I, Howard J, Herbert J. Disease exacerbation after rituximab induction in neuromyelitis optica. Neurol Neuroimmunol Neuroinflamm. 2015 Feb 05;2(1):e61. doi: 10.1212/NXI.0000000000000061. eCollection 2015 Feb. PMID: 25738163; PMCID: PMC4335814.
Copy Download .nbib Format: NLM
Share it on

Neurol Neuroimmunol Neuroinflamm. 2015 Feb 05;2(1):e61. doi: 10.1212/NXI.0000000000000061. eCollection 2015 Feb.

Disease exacerbation after rituximab induction in neuromyelitis optica.

Neurology(R) neuroimmunology & neuroinflammation

Jai S Perumal, Ilya Kister, Jonathan Howard, Joseph Herbert

Affiliations

  1. Department of Neurology (J.S.P.), Weill Cornell Medical College, New York, NY; and Department of Neurology (I.K., J. Howard, J. Herbert), New York University School of Medicine, New York, NY.

PMID: 25738163 PMCID: PMC4335814 DOI: 10.1212/NXI.0000000000000061

[No abstract available.]

References

  1. Neurologist. 2011 Mar;17(2):98-104 - PubMed
  2. Arch Neurol. 2008 Nov;65(11):1443-8 - PubMed
  3. Neurology. 2013 Aug 20;81(8):710-3 - PubMed
  4. Neurology. 2005 Apr 12;64(7):1270-2 - PubMed
  5. J Neurol Sci. 2013 Jan 15;324(1-2):38-9 - PubMed
  6. Neurology. 2011 Apr 12;76(15):1310-5 - PubMed
  7. Mult Scler. 2011 Oct;17(10):1225-30 - PubMed

Publication Types